Ryan J. Watts, President and CEO at Denali Therapeutics Inc. (DNLI), sold 31,866 shares at $30.59 ($938K) on 2023-02-09, disclosed to the SEC on 2023-02-13.
Open-market sale of $938k DNLI by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.59 | 3,433 | $105K | 11.2% |
| 2 | $30.59 | 3,433 | $105K | 11.2% |
| 3 | $29.10 | 25,000 | $728K | 77.6% |
| Total | $29.42 avg | 31,866 | $938K | 100% |
| Filing → |
| DNLI | SELL | 2025-01-08 | $1.5M | — | Filing → |
| DNLI | SELL | 2024-10-22 | $1.1M | — | Filing → |
| DNLI | SELL | 2024-08-22 | $108K | — | Filing → |